Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism

Research output: Contribution to journal › Review › Research › peer-review

Standard

Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism. / Schilbach, Katharina; Junnila, Riia Karoliina; Bidlingmaier, Martin.

In: Experimental and Clinical Endocrinology and Diabetes, Vol. 127, No. 2-3, 02.2019, p. 84-92.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Schilbach, K, Junnila, RK & Bidlingmaier, M 2019, 'Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism', Experimental and Clinical Endocrinology and Diabetes, vol. 127, no. 2-3, pp. 84-92. https://doi.org/10.1055/a-0672-0836

APA

Schilbach, K., Junnila, R. K., & Bidlingmaier, M. (2019). Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism. Experimental and Clinical Endocrinology and Diabetes, 127(2-3), 84-92. https://doi.org/10.1055/a-0672-0836

Vancouver

Schilbach K, Junnila RK, Bidlingmaier M. Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism. Experimental and Clinical Endocrinology and Diabetes. 2019 Feb;127(2-3):84-92. https://doi.org/10.1055/a-0672-0836

Author

Schilbach, Katharina ; Junnila, Riia Karoliina ; Bidlingmaier, Martin. / Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism. In: Experimental and Clinical Endocrinology and Diabetes. 2019 ; Vol. 127, No. 2-3. pp. 84-92.

Bibtex

@article{f8570cb072ae481db821166a0e78b468,
title = "Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism",
abstract = "Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary hypertension. Determining the aldosterone to renin ratio (ARR) in hypertensive patients has been shown to be a valuable screening test for identification of patients suffering from PA. Since the introduction of a more widespread ARR screening the number of PA patients significantly increased worldwide. Interpretation of ARR might be challenging: Several factors from posture to interfering drugs affect the ARR and need to be taken into account when collecting samples. In addition, the wide variety of available assay methods and lack of well-established cut-offs present a challenge to the clinician. This review discusses the usefulness and possible difficulties of ARR screening.",
keywords = "hypertension, primary aldosteronism, immunoassays, interfering drugs",
author = "Katharina Schilbach and Junnila, {Riia Karoliina} and Martin Bidlingmaier",
year = "2019",
month = feb,
doi = "10.1055/a-0672-0836",
language = "English",
volume = "127",
pages = "84--92",
journal = "Experimental and Clinical Endocrinology and Diabetes",
issn = "0947-7349",
publisher = "Johann Ambrosius Barth Verlag in Medizinverlage Heidelberg GmbH & Co. KG",
number = "2-3",

}

RIS

TY - JOUR

T1 - Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism

AU - Schilbach, Katharina

AU - Junnila, Riia Karoliina

AU - Bidlingmaier, Martin

PY - 2019/2

Y1 - 2019/2

N2 - Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary hypertension. Determining the aldosterone to renin ratio (ARR) in hypertensive patients has been shown to be a valuable screening test for identification of patients suffering from PA. Since the introduction of a more widespread ARR screening the number of PA patients significantly increased worldwide. Interpretation of ARR might be challenging: Several factors from posture to interfering drugs affect the ARR and need to be taken into account when collecting samples. In addition, the wide variety of available assay methods and lack of well-established cut-offs present a challenge to the clinician. This review discusses the usefulness and possible difficulties of ARR screening.

AB - Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary hypertension. Determining the aldosterone to renin ratio (ARR) in hypertensive patients has been shown to be a valuable screening test for identification of patients suffering from PA. Since the introduction of a more widespread ARR screening the number of PA patients significantly increased worldwide. Interpretation of ARR might be challenging: Several factors from posture to interfering drugs affect the ARR and need to be taken into account when collecting samples. In addition, the wide variety of available assay methods and lack of well-established cut-offs present a challenge to the clinician. This review discusses the usefulness and possible difficulties of ARR screening.

KW - hypertension

KW - primary aldosteronism

KW - immunoassays

KW - interfering drugs

U2 - 10.1055/a-0672-0836

DO - 10.1055/a-0672-0836

M3 - Review

C2 - 30165708

VL - 127

SP - 84

EP - 92

JO - Experimental and Clinical Endocrinology and Diabetes

JF - Experimental and Clinical Endocrinology and Diabetes

SN - 0947-7349

IS - 2-3

ER -

ID: 229268125